﻿<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.google.com/schemas/sitemap/0.84 http://www.google.com/schemas/sitemap/0.84/sitemap.xsd">
  <url>
    <loc>http://epogen.legalview.com/news-articles/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/no-party-for-healthcare-investors-one-year-later-mar-23-2011/1314957/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/after-a-husbands-death-am-i-ready-to-let-go-of-his-things-the-boston-g/1314956/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/fda-issues-guidance-on-glass-contamination-inpharm/1314955/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/amgen-boosts-biotech-sector-to-close-up-biotech-stocks-marketwatch/1314954/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/amgn-pphm-atvi-pwer-akam-stocks-to-watch-at-nasdaq-tapebeat/1268139/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/goldman-says-sell-amgen-benzingacom/1268138/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/corporate-watch-wsjcom/1248945/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/cms-expects-12-percent-increase-in-dialysis-patient-copays/1238318/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/opposing-views-top-10-us-pharmaceutical-sales-overpriced-brand-name-me/1229151/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/big-pharma-takes-on-risk-with-biosimilar-programs-fiercebiotech/1229150/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/how-epogen-helps-anemia-by-yvonne-mcdonald-helium/1229149/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/india-to-be-battleground-for-off-patent-biotech-drugs-dnaindiacom/1203799/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/amgen-ceo-looking-for-international-acquisitions-reuters/1203798/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/what-ails-amgen/1203797/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/will-prolia-be-amgens-billion-dollar-baby-san-fernando-valley-business/1193537/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/dennis-fenton-nominated-for-election-to-genzymes-board-of-directors-ma/1193536/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/more-good-news-for-amgen-as-denosumab-shows-promise-in-cancer-patients/1193535/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/pacific-coast-business-times-has-amgen-solved-its-conundrum/1193534/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles//1184119/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/no-biogenerics-from-pfizer-gooznews/1174470/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/affymax-hires-genentech-exec-orwin-as-operating-chief-wsjcom/1174469/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/can-amgen-rise-to-80-a-share/1174468/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/higher-sales-boost-amgens-profit-marketwatch/1174467/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/pharmacy-drug-store-news/1158856/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/welcome-to-nephronline-property-of-grand-view-media-group/1150456/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
</urlset>
